Profitability
Weight: 25%
B-
67
- 5yr Avg ROIC 11.0%
- Operating Margin Trend +0.53 pp/yr
CPRX
Catalyst Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
C-
48
- 5yr Avg ROE 12.0%
- 5yr Share-Count CAGR 4.2%
Growth Quality
Weight: 25%
A+
100
- 5yr Revenue CAGR 43.0%
- 5yr EPS CAGR 46.0%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A+
98
- 5yr FCF Margin 39.2%
- 5yr FCF/NI Conversion 1.24x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -2.39x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 19.81
Stability
Weight: 5%
C-
48
- EPS Volatility (σ/μ) 0.61
- Piotroski F-Score 4
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 4 gurus held; 1 new buy; 1 added; 2 trimmed.
- Holders
- 4 +1
- Avg Δ position
- +66.7%
- New buys
- 1
- Full exits
- 0